ENDOLOGIX INC's ticker is ELGX and the CUSIP is 29266S106. A total of 135 filers reported holding ENDOLOGIX INC in Q2 2013. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2014 | $35,121,000 | -99.9% | 2,309,078 | -49.6% | 0.02% | -43.8% |
| Q1 2014 | $59,005,012,000 | -6.9% | 4,584,694 | +26.2% | 0.03% | -11.1% |
| Q4 2013 | $63,363,427,000 | -8.8% | 3,633,224 | -15.6% | 0.04% | -16.3% |
| Q3 2013 | $69,476,309,000 | +7.3% | 4,304,604 | -11.7% | 0.04% | -2.3% |
| Q2 2013 | $64,755,325,000 | – | 4,876,154 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tamarack Capital Management, LLC | 4,050,000 | $62,127,000 | 7.14% |
| Essex Woodlands Management, Inc. | 1,257,468 | $24,875,000 | 4.49% |
| First Light Asset Management, LLC | 304,602 | $4,673,000 | 2.20% |
| ArrowMark Colorado Holdings LLC | 3,464,775 | $53,150,000 | 1.30% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,449,897 | $37,581,000 | 1.25% |
| Iguana Healthcare Management, LLC | 200,000 | $3,068,000 | 0.97% |
| WASHINGTON CAPITAL MANAGEMENT, INC | 82,316 | $1,262,000 | 0.71% |
| PALISADE CAPITAL MANAGEMENT, LP | 1,651,798 | $25,339,000 | 0.64% |
| PERKINS CAPITAL MANAGEMENT INC | 34,200 | $525,000 | 0.46% |
| CADIAN CAPITAL MANAGEMENT, LP | 967,443 | $14,841,000 | 0.44% |